Allergy Therapeutics presents findings at EAACI | Company Announcement
Investegate announcements from Allergy Therapeutics presents findings at EAACI
Stay updated with breaking news from Manuel Llobet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Allergy Therapeutics presents findings at EAACI
Allergy Therapeutics PLC on Tuesday said it has commenced subcutaneous dosing of peanut allergic patients in its phase 1/2a Protect trial. The Sussex, England-based biotechnology company said the...
Allergy Therapeutics PLC on Tuesday resumed trading on AIM after the release of its annual results. Shares in the Sussex-based biotechnology company specialising in allergy vaccines were suspended...
Allergy Therapeutics PLC on Wednesday said that phase-3 trials of its grass allergy injection yielded positive results, moving the product closer to market entry. The Sussex-based biotechnology...
The following stocks are the leading risers and fallers on AIM in London on Wednesday. ---------- AIM - WINNERS ---------- Impellam Group PLC, up 26% at 819.12 pence, 12-month range 580.00p-950.00p....